NEW YORK (Reuters Health) – Although the pharmacokinetics (PK) and pharmacodynamics (PD) of high-dose human regular U-500 and human regular U-100 insulin are similar, the U-500 formulation may…
NEW YORK (Reuters Health) – Insulin resistance shows no significant association with an increased risk of atrial fibrillation, researchers report in an October 14th on-line paper in the…
NEW YORK (Reuters Health) – Vandetanib shows encouraging action against advanced and metastatic medullary thyroid carcinoma, researchers report in an October 24th on-line paper in the Journal of…
NEW YORK (Reuters Health) – More intensive blood glucose lowering won’t reduce the risk of heart failure in patients with type 2 diabetes, and when achieved with a…
NEW YORK (Reuters Health) – Polycystic ovary syndrome (PCOS) does not appear to increase the risk of cardiovascular events among postmenopausal women, researchers from Sweden report in the…
NEW YORK (Reuters Health) – Insulin sensitizers may reduce the accelerated loss in muscle mass and strength seen in elderly men with type 2 diabetes, according to a…
NEW YORK (Reuters Health) – Bariatric surgery and its associated weight loss significantly improve the cardiovascular risk profile of obese patients, according to findings published in the August…
NEW YORK (Reuters Health) – Lifestyle changes and treatment with metformin may offset the development of the metabolic syndrome related to androgen deprivation therapy in men with prostate…
NEW YORK (Reuters Health) – Patients with diabetes achieve faster control of A1C, blood pressure and cholesterol targets when they see or have contact with their primary care…
NEW YORK (Reuters Health) – Women with familial hypercholesterolemia (FH) do not appear to be at increased risk of adverse pregnancy outcomes, Norwegian researchers report in a September…